SUDARSHAN PHARMA INDUSTRIES LI (SUDARSHAN.BO)

INR 39.63

(-1.95%)

Annual Income Statements

(In INR)
Breakdown 2024 2023 2022 2021 2020
Revenue 4.63 Billion 4.61 Billion 3.57 Billion 1.93 Billion 1.47 Billion
Cost of Revenue 4.27 Billion 4.42 Billion 3.43 Billion 1.81 Billion 1.39 Billion
Gross Profit 361.76 Million 192.75 Million 139.17 Million 119.33 Million 82.66 Million
Operating Expenses 146.09 Million 50.56 Million 37.66 Million 55.11 Million 32.04 Million
Selling, General and Administrative Expenses 146.09 Million 50.56 Million 37.66 Million 55.11 Million 32.04 Million
Research and Development Expenses - - - - -
Other Expenses - - - - -
Cost and Expenses 4.41 Billion 4.47 Billion 3.46 Billion 1.86 Billion 1.42 Billion
Operating Income 215.67 Million 142.19 Million 101.5 Million 64.22 Million 50.62 Million
Interest Expense 89.44 Million 54.02 Million 33.79 Million 32.25 Million 27.22 Million
Income Tax Expense 37.73 Million 24.59 Million 18.87 Million 9.03 Million 4.4 Million
Earnings before Tax 152.28 Million 94.96 Million 71.35 Million 35.74 Million 17.15 Million
Net Income 114.55 Million 70.36 Million 52.47 Million 26.71 Million 12.75 Million
Earnings Per Share Basic 4.76 5.48 5.46 1.12 0.53
Earnings Per Share Diluted 4.76 5.48 5.46 1.12 0.53
Weighted Average Shares Outstanding 24.06 Million 12.85 Million 9.61 Million 23.9 Million 23.9 Million
Weighted Average Shares Outstanding (Diluted) 24.06 Million 12.85 Million 9.61 Million 23.9 Million 23.9 Million
Gross Margin 0.08 0.04 0.04 0.06 0.06
EBIT Margin 0.05 0.03 0.03 0.04 0.04
Profit Margin 0.02 0.02 0.01 0.01 0.01
EBITDA 254.17 Million 151.26 Million 110.16 Million 71.64 Million 47.85 Million
Earnings Before Tax Margin 0.05 0.03 0.03 0.03 0.03

Income Statement Charts